Nutrient restriction in utero induces remodeling of the vascular extracellular matrix in rat offspring

Reproductive Sciences

Volumn 14, Issue 1, 2007, Pages 73-80

  Khorram, Omid ^a   Momeni, Mazdak ^a   Desai, Mina ^a   Ross, Michael G ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Aorta; Collagen; Elastin; Extracellular matrix; Glycosaminoglycans; Maternal food restriction; Mesenteric arterioles

Indexed keywords

COLLAGEN; ELASTIN; GELATINASE A; GELATINASE B; GLYCOSAMINOGLYCAN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIOLE; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; EXTRACELLULAR MATRIX; MATERNAL NUTRITION; MESENTERIC ARTERY; NONHUMAN; NUTRIENT LIMITATION; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROGENY; RAT; UTERUS; VASCULAR RESISTANCE; AGING; ANIMAL; BIRTH WEIGHT; DISEASE MODEL; FEMALE; HEART VENTRICLE REMODELING; MALE; MALNUTRITION; NEWBORN; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; REFERENCE VALUE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT;

AGING; ANIMALS; ANIMALS, NEWBORN; BIRTH WEIGHT; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; FEMALE; MALE; MALNUTRITION; PREGNANCY; PREGNANCY COMPLICATIONS; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VENTRICULAR REMODELING;

EID: 34247262000     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719106298215     Document Type: Article

References (37)

1. Barker DJ, Osmond C. Death rates from stroke in England and Wales predicted from past maternal mortality. Br Med J (Clin Res Ed). 1987 ; 295: 83-86.
2. Gennser G, Rymark P, Isberg PE. Low birth weight and risk of high blood pressure in adulthood. Br Med J (Clin Res Ed). 1988 ; 296: 1498-1500.
3. McMillen IC, Robinson JS. Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev. 2005 ; 85: 571-633.
4. Pladys P, Sennlaub F, Brault S, et al. Microvascular rarefaction and decreased angiogenesis in rats with fetal programming of hypertension associated with exposure to a low protein diet in utero. Am J Physiol Regul Integr Comp Physiol. 2005 ; 289: R1580 - R1588.
5. Armitage JA, Lakasing L, Taylor PD, et al. Developmental programming of aortic and renal structure in offspring of rats fed fat-rich diets in pregnancy. J Physiol. 2005 ; 565: 171-184.
6. Brawley L, Poston L, Hanson MA. Mechanisms underlying the programming of small artery dysfunction: review of the model using low protein diet in pregnancy in the rat. Arch Physiol Biochem. 2003 ; 111: 23-35.
7. Shadwick RE. Mechanical design in arteries. J Exp Biol. 1999 ; 202: 3305-3313.
8. Dobrin PB. Mechanical properties of arteries. Physiol Rev. 1978 ; 58: 397-460.
9. Behmoaras J, Osborne-Pellegrin M, Gauguier D, Jacob MP. Characteristics of the aortic elastic network and related phenotypes in seven inbred rat strains. Am J Physiol Heart Circ Physiol. 2005 ; 288: H769 - H777.
10. Kreese H, Schonherr E. Proteoglycan of the extracellular matrix and growth control. J Cell Physiol. 2001 ; 189: 266-274.
11. Foster JA, Rich CB, Miller M, Benedict MR, Richman RA, Florini JR. Effect of age and IGF-I administration on elastin gene expression in rat aorta. J Gerontol. 1990 ; 45: B113 - B118.
12. Kahari VM, Olsen DR, Rhudy RW, Carrillo P, Chen YQ, Uitto J. Transforming growth factor-beta up-regulates elastin gene expression in human skin fibroblasts. Evidence for posttranscriptional modulation. Lab Invest. 1992 ; 66: 580-588.
13. Desai M, Gayle D, Babu J, Ross MG. Programmed obesity in intrauterine growth-restricted newborns: modulation by newborn nutrition. Am J Physiol Regul Integr Comp Physiol. 2005 ; 288: R91 - R96.
14. Momeni M, Han G, Ross MG, Desai M, Khorram O. Maternal food restricts (FR) induces remodeling of the vascular extracellular matrix in the offspring. J Soc Gyn Invest. 2006 ; 13 (suppl). 185A - 185A.
15. Kielty CM, Sherratt MJ, Marson A, Baldock C. Fibrillin microfibrils. Adv Protein Chem. 2005 ; 70: 405-436.
16. Karnik SK, Brooke BS, Bayes-Genis A, et al. A critical role for elastin signaling in vascular morphogenesis and disease. Development. 2003 ; 130: 411-423.
17. Sadoun E, Reed MJ. Impaired angiogenesis in aging is associated with alterations in vessel density, matrix composition, inflammatory response,and growth factor expression. J Histochem Cytochem. 2003 ; 51: 1119-1130.
18. Laurent S, Boutouyrie P, Lacolley P. Structural and genetic bases of arterial stiffness. Hypertension. 2005 ; 45: 1050-1055.
19. Briones AM, Gonzales JM, Somoza B, et al. Role of elastin in spontaneously hypertensive rat small mesenteric artery remodeling. J Physiol. 2003 ; 552: 185-189.
20. Wight TN. Cell biology of arterial proteoglycans. Arteriosclerosis. 1989 ; 9: 1-20.
21. Gandley RE, McLaughlin MK, Koob TJ, Little SA, McGuffee LJ. Contribution of chondroitin-dermatan sulfate-containing proteoglycans to the function of rat mesenteric arteries. Am J Physiol. 1997 ; 273: H952 - H960.
22. Et-Taouil K, Schiavi P, Levy BI, Plante GE. Sodium intake, large artery stiffness, and proteoglycans in the spontaneously hypertensive rat. Hypertension. 2001 ; 38: 1172-1176.
23. Martin H, Hu J, Gennser G, Norman M. Impaired endothelial function and increased carotid stiffness in 9-year old children with low birth-weight. Circulation. 2000 ; 102: 2739-2744.
24. Riedel M, Rafflenbeul W, Lichten P. Ovarian sex steroids and atheroscerosis. Clin Investig. 1993 ; 71: 406-412.
25. Vassilev V, Pretto CM, Coronet PB, et al. Response of matrix metalloproteinases and tissue inhibitors of metalloproteinases messenger ribonucleic acids to ovarian steroids in human endometrial explants mimics their gene and phase-specific differential control in vivo. J Clin Endocrinol Metab. 2005 ; 90: 5848-5857.
26. Jacob MP. Extracellular matrix remodeling and matrix metalloproteinases in the vascular wall during aging and in pathological conditions. Biomed Pharmacother. 2003 ; 57: 195-202.
27. Van der RM, Garrone R. Collagen family of proteins. FASEB J. 1991 ; 5: 2814-2823.
28. Yasmin, Wallace S, McEniery CM, et al. Matrix metalloproteinase-9 (MMP-9), MMP-2 and serum elastase activity are associated with systolic hypertension and arterial stiffness. Artioscler Thromb Vasc Biol. 2005 ; 25: 372-378.
29. Blankenberg S, Rupprecht HJ, Poirier O, et al. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation. 2003 ; 107: 1579-1585.
30. Borden P, Heller RA. Transcriptional control of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases. Crit Rev Eukaryot Gene Expr. 1997 ; 7: 159-178.
31. Kossakowska AE, Edwards DR, Prusinkiewicz C, et al. Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP- 1) expression in non-Hodgkin's lymphomas. Blood. 1999 ; 94: 2020-2029.
32. Takeshita S, Tokutomi T, Kawase H, et al. Elevated serum levels of matrix metalloproteinase-9 (MMP-9) in Kawasaki disease. Clin Exp Immunol. 2001 ; 125: 340-344.
33. Nkkari ST, Hoyhtya M, Isola J, Nikkari T. Macrophages contain 92-kd gelatinase (MMP-9) at the site of degenerated internal elastic lamina in temporal arteritis. Am J Pathol. 1996 ; 149: 1427-1433.
34. Intengan HD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, inflammation and fibrosis. Hypertension. 2001 ; 38: 581-587.
35. Lee T, Esemuede N, Sumpio BE, Gahtan V. Thrombospond in-1 induces matrix metalloproteinase-2 activation in vascular smooth muscle cells. J Vasc Surg. 2003 ; 38: 147-154.
36. Touyz RM. Intracellular mechanisms involved in vascular remodeling of resistance arteries in hypertension:role of angiotensin ll. Exp Physiol. 2005 ; 90: 449-455.
37. Mey JGR, Schiffers PM, Hilgers RHP, Sanders MM. Toward functional genomics of flow-induced outward remodeling of resistance arteries. Am J Physiol Heart Circ Physiol. 2005 ; 288: H1022 - H1027.